284 related articles for article (PubMed ID: 21496863)
1. L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma.
Choi SY; Jo YS; Huang SM; Liang ZL; Min JK; Hong HJ; Kim JM
Hum Pathol; 2011 Oct; 42(10):1476-83. PubMed ID: 21496863
[TBL] [Abstract][Full Text] [Related]
2. L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma.
Li S; Jo YS; Lee JH; Min JK; Lee ES; Park T; Kim JM; Hong HJ
Clin Cancer Res; 2009 Dec; 15(23):7345-51. PubMed ID: 19920102
[TBL] [Abstract][Full Text] [Related]
3. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
[TBL] [Abstract][Full Text] [Related]
4. Positive expression of L1-CAM is associated with perineural invasion and poor outcome in pancreatic ductal adenocarcinoma.
Ben QW; Wang JC; Liu J; Zhu Y; Yuan F; Yao WY; Yuan YZ
Ann Surg Oncol; 2010 Aug; 17(8):2213-21. PubMed ID: 20162456
[TBL] [Abstract][Full Text] [Related]
5. L1 Cell adhesion molecule (L1CAM) expression at the cancer invasive front is a novel prognostic marker of pancreatic ductal adenocarcinoma.
Tsutsumi S; Morohashi S; Kudo Y; Akasaka H; Ogasawara H; Ono M; Takasugi K; Ishido K; Hakamada K; Kijima H
J Surg Oncol; 2011 Jun; 103(7):669-73. PubMed ID: 21360711
[TBL] [Abstract][Full Text] [Related]
6. Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.
Lee HJ; Lee K; Lee DG; Bae KH; Kim JS; Liang ZL; Huang SM; Suk Oh Y; Kim HY; Jo DY; Min JK; Kim JM; Lee HJ
Clin Cancer Res; 2012 Jun; 18(12):3270-80. PubMed ID: 22553346
[TBL] [Abstract][Full Text] [Related]
7. The cell adhesion molecule L1 promotes gallbladder carcinoma progression in vitro and in vivo.
Jung J; Son YS; Park H; Jeon SK; Lee JW; Choi SY; Kim JM; Kwon YG; Hong HJ; Min JK
Oncol Rep; 2011 Apr; 25(4):945-52. PubMed ID: 21318226
[TBL] [Abstract][Full Text] [Related]
8. Loss of estrogen receptor beta expression at cancer front correlates with tumor progression and poor prognosis of gallbladder cancer.
Sumi K; Matsuyama S; Kitajima Y; Miyazaki K
Oncol Rep; 2004 Nov; 12(5):979-84. PubMed ID: 15492781
[TBL] [Abstract][Full Text] [Related]
9. L1, β-catenin, and E-cadherin expression in patients with colorectal cancer: correlation with clinicopathologic features and its prognostic significance.
Fang QX; Lü LZ; Yang B; Zhao ZS; Wu Y; Zheng XC
J Surg Oncol; 2010 Oct; 102(5):433-42. PubMed ID: 20672319
[TBL] [Abstract][Full Text] [Related]
10. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
[TBL] [Abstract][Full Text] [Related]
11. Aerodigestive tract invasion by well-differentiated thyroid carcinoma: diagnosis, management, prognosis, and biology.
McCaffrey JC
Laryngoscope; 2006 Jan; 116(1):1-11. PubMed ID: 16481800
[TBL] [Abstract][Full Text] [Related]
12. Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma.
Du X; Wang S; Lu J; Cao Y; Song N; Yang T; Dong R; Zang L; Yang Y; Wu T; Li J
Jpn J Clin Oncol; 2011 Sep; 41(9):1086-93. PubMed ID: 21835828
[TBL] [Abstract][Full Text] [Related]
13. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
Liu DC; Yang ZL
Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
[TBL] [Abstract][Full Text] [Related]
15. Heparanase expression in gallbladder carcinoma and its correlation to prognosis.
Wu W; Pan C; Yu H; Gong H; Wang Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):491-7. PubMed ID: 17524042
[TBL] [Abstract][Full Text] [Related]
16. Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma.
Rawnaq T; Kleinhans H; Uto M; Schurr PG; Reichelt U; Cataldegirmen G; Gawad KA; Yekebas EF; Schachner M; Izbicki JR; Kaifi JT
Anticancer Res; 2009 Apr; 29(4):1195-9. PubMed ID: 19414364
[TBL] [Abstract][Full Text] [Related]
17. Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma. A systematic analysis including primary and corresponding metastatic tumours.
Kornprat P; Rehak P; Rüschoff J; Langner C
J Clin Pathol; 2006 Feb; 59(2):202-6. PubMed ID: 16443739
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of fascin-1 expression is more significant in advanced colorectal cancer.
Oh SY; Kim YB; Suh KW; Paek OJ; Moon HY
J Surg Res; 2012 Jan; 172(1):102-8. PubMed ID: 20851411
[TBL] [Abstract][Full Text] [Related]
19. RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer.
Oshikiri T; Hida Y; Miyamoto M; Hashida H; Katoh K; Suzuoki M; Nakakubo Y; Hiraoka K; Shinohara T; Itoh T; Kondo S; Katoh H
Br J Cancer; 2001 Dec; 85(12):1922-7. PubMed ID: 11747335
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of sialyl Lex expression in human gallbladder carcinoma.
Kashiwagi H; Kijima H; Dowaki S; Ohtani Y; Tobita K; Yamazaki H; Nakamura M; Ueyama Y; Tanaka M; Inokuchi S; Imaizumi T; Makuuchi H
Oncol Rep; 2004 Jun; 11(6):1139-43. PubMed ID: 15138547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]